Reduced airway hyperresponsiveness and tracheal responses during allergic asthma in mice lacking tyrosine kinase inducible T-cell kinase

Tanna Janelle Boyer, Cynthia Mueller, Nisebita Sahu, Abdellaziz Ben-Jebria, Avery August

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Background: Patients with allergic asthma have symptoms of a predominant T H2 response, including airway eosinophilic inflammation and increased mucous production in the lungs. This accompanies increased airways responsiveness, which can be life threatening. Because T H2 cells and cytokines have been implicated in contributing to these symptoms, pathways that control the development of these cells or that regulate their cytokine production represent good targets for controlling this disease. Objective: We have previously shown that mice lacking the tyrosine kinase inducible T-cell kinase (ITK) have drastically reduced airway inflammation in a model of allergic asthma. However, it was not clear whether this translated into reduced airways hyperresponsiveness. We have analyzed tracheal responsiveness and airways hyperresponsiveness of wild-type (WT) and ITK null mice during induction of experimental allergic asthma. Methods: Experimental allergic asthma was induced in WT and ITK knockout mice. Tracheal responses to carbachol, acetylcholine, and potassium chloride were analyzed. Airways hyperresponsiveness to methacholine challenge was also analyzed in allergen-challenged mice, along with lung and bronchoalveolar lavage fluid T H2 cytokine message and protein. Results: ITK null mice have reduced tracheal responses to cholinergic challenge in vitro before as well as after allergen challenge. These mice also have reduced airways hyperresponsiveness in response to allergen challenge, which could be rescued by transferring WT splenocytes or purified WT CD4 + T cells. This reduced airways response was preferentially accompanied by reduced expression of T H2 cytokines in the lungs. Conclusion: Our results indicate that the tyrosine kinase ITK and its function in T cells represent an attractive target for antiasthmatic drugs. Clinical implications: Modulating the expression or activity of ITK may be a novel strategy to block allergic airway inflammation.

Original languageEnglish (US)
Pages (from-to)780-786
Number of pages7
JournalJournal of Allergy and Clinical Immunology
Volume117
Issue number4
DOIs
StatePublished - Apr 1 2006

Fingerprint

Protein-Tyrosine Kinases
Asthma
Allergens
Cytokines
Bronchoalveolar Lavage Fluid
Inflammation
Anti-Asthmatic Agents
T-Lymphocytes
Lung
Potassium Chloride
Methacholine Chloride
Carbachol
Knockout Mice
Cholinergic Agents
Acetylcholine
emt protein-tyrosine kinase
Proteins

Keywords

  • Airways hyperresponsiveness
  • T 2 cells
  • Tec kinase
  • asthma
  • cytokines
  • smooth muscle contractility
  • tracheal responses

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Reduced airway hyperresponsiveness and tracheal responses during allergic asthma in mice lacking tyrosine kinase inducible T-cell kinase. / Boyer, Tanna Janelle; Mueller, Cynthia; Sahu, Nisebita; Ben-Jebria, Abdellaziz; August, Avery.

In: Journal of Allergy and Clinical Immunology, Vol. 117, No. 4, 01.04.2006, p. 780-786.

Research output: Contribution to journalArticle

Boyer, Tanna Janelle ; Mueller, Cynthia ; Sahu, Nisebita ; Ben-Jebria, Abdellaziz ; August, Avery. / Reduced airway hyperresponsiveness and tracheal responses during allergic asthma in mice lacking tyrosine kinase inducible T-cell kinase. In: Journal of Allergy and Clinical Immunology. 2006 ; Vol. 117, No. 4. pp. 780-786.
@article{49607b00178547e7a2e0a217c2c872b7,
title = "Reduced airway hyperresponsiveness and tracheal responses during allergic asthma in mice lacking tyrosine kinase inducible T-cell kinase",
abstract = "Background: Patients with allergic asthma have symptoms of a predominant T H2 response, including airway eosinophilic inflammation and increased mucous production in the lungs. This accompanies increased airways responsiveness, which can be life threatening. Because T H2 cells and cytokines have been implicated in contributing to these symptoms, pathways that control the development of these cells or that regulate their cytokine production represent good targets for controlling this disease. Objective: We have previously shown that mice lacking the tyrosine kinase inducible T-cell kinase (ITK) have drastically reduced airway inflammation in a model of allergic asthma. However, it was not clear whether this translated into reduced airways hyperresponsiveness. We have analyzed tracheal responsiveness and airways hyperresponsiveness of wild-type (WT) and ITK null mice during induction of experimental allergic asthma. Methods: Experimental allergic asthma was induced in WT and ITK knockout mice. Tracheal responses to carbachol, acetylcholine, and potassium chloride were analyzed. Airways hyperresponsiveness to methacholine challenge was also analyzed in allergen-challenged mice, along with lung and bronchoalveolar lavage fluid T H2 cytokine message and protein. Results: ITK null mice have reduced tracheal responses to cholinergic challenge in vitro before as well as after allergen challenge. These mice also have reduced airways hyperresponsiveness in response to allergen challenge, which could be rescued by transferring WT splenocytes or purified WT CD4 + T cells. This reduced airways response was preferentially accompanied by reduced expression of T H2 cytokines in the lungs. Conclusion: Our results indicate that the tyrosine kinase ITK and its function in T cells represent an attractive target for antiasthmatic drugs. Clinical implications: Modulating the expression or activity of ITK may be a novel strategy to block allergic airway inflammation.",
keywords = "Airways hyperresponsiveness, T 2 cells, Tec kinase, asthma, cytokines, smooth muscle contractility, tracheal responses",
author = "Boyer, {Tanna Janelle} and Cynthia Mueller and Nisebita Sahu and Abdellaziz Ben-Jebria and Avery August",
year = "2006",
month = "4",
day = "1",
doi = "10.1016/j.jaci.2005.12.1330",
language = "English (US)",
volume = "117",
pages = "780--786",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Reduced airway hyperresponsiveness and tracheal responses during allergic asthma in mice lacking tyrosine kinase inducible T-cell kinase

AU - Boyer, Tanna Janelle

AU - Mueller, Cynthia

AU - Sahu, Nisebita

AU - Ben-Jebria, Abdellaziz

AU - August, Avery

PY - 2006/4/1

Y1 - 2006/4/1

N2 - Background: Patients with allergic asthma have symptoms of a predominant T H2 response, including airway eosinophilic inflammation and increased mucous production in the lungs. This accompanies increased airways responsiveness, which can be life threatening. Because T H2 cells and cytokines have been implicated in contributing to these symptoms, pathways that control the development of these cells or that regulate their cytokine production represent good targets for controlling this disease. Objective: We have previously shown that mice lacking the tyrosine kinase inducible T-cell kinase (ITK) have drastically reduced airway inflammation in a model of allergic asthma. However, it was not clear whether this translated into reduced airways hyperresponsiveness. We have analyzed tracheal responsiveness and airways hyperresponsiveness of wild-type (WT) and ITK null mice during induction of experimental allergic asthma. Methods: Experimental allergic asthma was induced in WT and ITK knockout mice. Tracheal responses to carbachol, acetylcholine, and potassium chloride were analyzed. Airways hyperresponsiveness to methacholine challenge was also analyzed in allergen-challenged mice, along with lung and bronchoalveolar lavage fluid T H2 cytokine message and protein. Results: ITK null mice have reduced tracheal responses to cholinergic challenge in vitro before as well as after allergen challenge. These mice also have reduced airways hyperresponsiveness in response to allergen challenge, which could be rescued by transferring WT splenocytes or purified WT CD4 + T cells. This reduced airways response was preferentially accompanied by reduced expression of T H2 cytokines in the lungs. Conclusion: Our results indicate that the tyrosine kinase ITK and its function in T cells represent an attractive target for antiasthmatic drugs. Clinical implications: Modulating the expression or activity of ITK may be a novel strategy to block allergic airway inflammation.

AB - Background: Patients with allergic asthma have symptoms of a predominant T H2 response, including airway eosinophilic inflammation and increased mucous production in the lungs. This accompanies increased airways responsiveness, which can be life threatening. Because T H2 cells and cytokines have been implicated in contributing to these symptoms, pathways that control the development of these cells or that regulate their cytokine production represent good targets for controlling this disease. Objective: We have previously shown that mice lacking the tyrosine kinase inducible T-cell kinase (ITK) have drastically reduced airway inflammation in a model of allergic asthma. However, it was not clear whether this translated into reduced airways hyperresponsiveness. We have analyzed tracheal responsiveness and airways hyperresponsiveness of wild-type (WT) and ITK null mice during induction of experimental allergic asthma. Methods: Experimental allergic asthma was induced in WT and ITK knockout mice. Tracheal responses to carbachol, acetylcholine, and potassium chloride were analyzed. Airways hyperresponsiveness to methacholine challenge was also analyzed in allergen-challenged mice, along with lung and bronchoalveolar lavage fluid T H2 cytokine message and protein. Results: ITK null mice have reduced tracheal responses to cholinergic challenge in vitro before as well as after allergen challenge. These mice also have reduced airways hyperresponsiveness in response to allergen challenge, which could be rescued by transferring WT splenocytes or purified WT CD4 + T cells. This reduced airways response was preferentially accompanied by reduced expression of T H2 cytokines in the lungs. Conclusion: Our results indicate that the tyrosine kinase ITK and its function in T cells represent an attractive target for antiasthmatic drugs. Clinical implications: Modulating the expression or activity of ITK may be a novel strategy to block allergic airway inflammation.

KW - Airways hyperresponsiveness

KW - T 2 cells

KW - Tec kinase

KW - asthma

KW - cytokines

KW - smooth muscle contractility

KW - tracheal responses

UR - http://www.scopus.com/inward/record.url?scp=33646017981&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646017981&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2005.12.1330

DO - 10.1016/j.jaci.2005.12.1330

M3 - Article

VL - 117

SP - 780

EP - 786

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 4

ER -